Splenic proportions of cDC were not only reduced after stroke in vehicle-treated mice (as mentioned earlier; p < 0.05), but were also strongly diminished after t-PA treatment in shams (i.e., under baseline conditions; p < 0.01; Figure 5B, 2nd panel from left), creating a 2-fold impact. The gene discussed is TBXT; the disease is Stroke.